Evaluating the effect of rapamycin treatment in Alzheimer's Disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol

Jonas E. Svensson; Martin Bolin; Daniel Thor; Pete A. Williams; Rune Brautaset; Marcus Carlsson; Peder Sörensson; David Marlevi; Rubens Spin-Neto; Monika Probst; Göran Hagman; Anton Forsberg Morén; Miia Kivipelto; Pontus Plavén-Sigray

doi:10.1101/2024.02.19.24302922

Evaluating the effect of rapamycin treatment in Alzheimer's Disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol

Jonas E. Svensson, Martin Bolin, Daniel Thor, View ORCID ProfilePete A. Williams, Rune Brautaset, Marcus Carlsson, Peder Sörensson, David Marlevi, Rubens Spin-Neto, Monika Probst, Göran Hagman, Anton Forsberg Morén, Miia Kivipelto, View ORCID ProfilePontus Plavén-Sigray

doi: https://doi.org/10.1101/2024.02.19.24302922

Jonas E. Svensson

1Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden

2Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin Bolin

1Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel Thor

3Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden

4Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pete A. Williams

5Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Pete A. Williams

Rune Brautaset

5Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcus Carlsson

6Clinical Physiology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden

7Department of Clinical Physiology, Karolinska University Hospital, and Karolinska Institutet, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peder Sörensson

7Department of Clinical Physiology, Karolinska University Hospital, and Karolinska Institutet, Stockholm, Sweden

8Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David Marlevi

7Department of Clinical Physiology, Karolinska University Hospital, and Karolinska Institutet, Stockholm, Sweden

9Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rubens Spin-Neto

10Department of Dentistry and Oral Health, Section for Oral Radiology, Aarhus University, Aarhus C, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Monika Probst

11Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Göran Hagman

2Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden

12Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anton Forsberg Morén

1Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Miia Kivipelto

2Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden

12Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden

13Ageing Epidemiology Research Unit (AGE), School of Public Health, Faculty of Medicine, Imperial College London, UK

14Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pontus Plavén-Sigray

1Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden

15Neurobiology Research Unit, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Pontus Plavén-Sigray
For correspondence: pontus.plaven-sigray{at}ki.se

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Supplementary Information[supplements/302922_file03.pdf]

View the discussion thread.

PreviousNext

Posted February 29, 2024.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Evaluating the effect of rapamycin treatment in Alzheimer's Disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Evaluating the effect of rapamycin treatment in Alzheimer's Disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol

Jonas E. Svensson, Martin Bolin, Daniel Thor, Pete A. Williams, Rune Brautaset, Marcus Carlsson, Peder Sörensson, David Marlevi, Rubens Spin-Neto, Monika Probst, Göran Hagman, Anton Forsberg Morén, Miia Kivipelto, Pontus Plavén-Sigray

medRxiv 2024.02.19.24302922; doi: https://doi.org/10.1101/2024.02.19.24302922

Share This Article: